BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:F01 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of F01\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06468683-5468@assetmemo.bio
DTSTAMP:20261121T004517Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:F01: Phase 1 readout est. (NCT06468683)
DESCRIPTION:F01\, phase 1\, Systemic Lupus Erythematosus.\nStudy: F01 in th
 e Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus\
 nEstimated primary completion: 31 January 2027. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/f01#upcoming-events\nRegistry record: https://c
 linicaltrials.gov/study/NCT06468683
URL:https://assetmemo.bio/drug/f01#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
